Pimpin Incharoen Selected Research

Pimpin Incharoen Research Topics

4	Neoplasms (Cancer) 01/2021 - 05/2013
3	Adenocarcinoma 09/2020 - 05/2016
2	Cryptococcosis 01/2021 - 11/2013
2	Disease Progression 05/2016 - 05/2013
1	Hemorrhage 01/2022
1	Anemia 01/2022
1	Osteoporosis 01/2022
1	Hemoptysis 01/2022
1	Tuberculosis (Tuberculoses) 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2021
1	Pulmonary Tuberculosis 01/2021
1	Fever (Fevers) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Melioidosis 01/2020
1	Pulmonary Edema 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Invasive Fungal Infections 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Mycoses (Diseases, Fungus) 01/2018
1	Carcinoma (Carcinomatosis) 12/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2016
1	Infections 11/2013
1	Triple Negative Breast Neoplasms 05/2013
1	Neoplasm Metastasis (Metastasis) 05/2013
1	Lupus Nephritis 02/2013

2	Anaplastic Lymphoma KinaseIBA 12/2016 - 05/2016
2	CrizotinibIBA 12/2016 - 05/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Denosumab FDA Link 01/2022
1	ruxolitinibIBA 01/2021
1	B7-H1 AntigenIBA 09/2020
1	AsbestosIBA 01/2019
1	Codon (Codons)IBA 08/2018
1	Sodium Glutamate (Accent)IBA 01/2018
1	AndrogensIBA 05/2013
1	EnzymesIBA 05/2013
1	Estrogen ReceptorsIBA 05/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2013
1	human ERBB2 proteinIBA 05/2013
1	Indicators and Reagents (Reagents)IBA 02/2013

4	Therapeutics 01/2021 - 05/2013
1	Aftercare (After-Treatment) 11/2013